Adjunct radiotherapy ‘improves DCIS outcomes’
Long-term follow-up shows that the benefits of radiotherapy wane after the first decade.
Long-term follow-up shows that the benefits of radiotherapy wane after the first decade.
The national BreastScreen scheme recorded 150,000 fewer mammograms than normal.
Interim results from the open-label trial suggest abemaciclib has benefit, researchers say.
Does the type of paclitaxel make a difference to outcomes?
The 32-year-old died after a delayed diagnosis, according to New Zealand's Health and Disability Commissioner.
A two-decade study shows screening at an earlier age cuts the risk of death from breast cancer.
But patient selection would be important, commentators say.
Sustained weight reduction of more than 2kg is associated with a benefit, say researchers.
Results support screening women at high familial risk of breast or ovarian cancer at a dedicated centre, say researchers.
Experts say it's clear rougher-surfaced implants confer the highest risk.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.